Skip to main content
Erschienen in: Medical Oncology 8/2014

01.08.2014 | Original Paper

Thyroid carcinoma after treatment for malignancies in childhood and adolescence: from diagnosis through follow-up

verfasst von: Marta Giorgia Podda, Monica Terenziani, Lorenza Gandola, Paola Collini, Natalia Pizzi, Alfonso Marchianò, Carlo Morosi, Roberto Luksch, Andrea Ferrari, Michela Casanova, Filippo Spreafico, Daniela Polastri, Cristina Meazza, Serena Catania, Elisabetta Schiavello, Veronica Biassoni, Maura Massimino

Erschienen in: Medical Oncology | Ausgabe 8/2014

Einloggen, um Zugang zu erhalten

Abstract

With improvements in the survival rates after childhood cancer, many clinicians have turned their attention to reporting on late effects, and how they might be prevented or treated. In childhood the thyroid gland is especially vulnerable to the carcinogenic action of ionizing radiation. This retrospective study focused on secondary thyroid cancers seen at our institution over more than 30 years (between 1980 and 2012) in patients treated for other malignancies in pediatric age. 36 patients were identified. In most cases, the primary cancer had been Hodgkin disease, and all the patients had been administered radiotherapy for their first malignancy. The secondary thyroid cancers were treated with total thyroidectomy in 27 cases (six with lymphadenectomy), and hemithyroidectomy in nine (one with lymphadenectomy). 12 Patients were also given radiometabolic therapy. All but two had TSH suppression therapy. The histological diagnoses were: 31 papillary and five follicular carcinomas. At 5 and 10 years, the OS was 100 and 95 %, respectively, and the PFS was 96 and 83 %. None of the patients died of their thyroid disease. Nodal involvement at onset was the only factor correlating with recurrence. Surgical sequelae only occurred in patients who underwent total thyroidectomy. Survival in these patients did not depend on the extent of surgery on the thyroid parenchyma. Our data confirm a good prognosis for secondary thyroid cancer, prompting us to encourage a minimalist approach to the treatment of these particular patients wherever possible.
Literatur
1.
Zurück zum Zitat Ron E, Modan B, Preston D, Alfandary E. Neoplasia following low-dose radiation in childhood. Radiat Res. 1989;120(3):516–31.PubMedCrossRef Ron E, Modan B, Preston D, Alfandary E. Neoplasia following low-dose radiation in childhood. Radiat Res. 1989;120(3):516–31.PubMedCrossRef
2.
Zurück zum Zitat Boice JD Jr. Thyroid disease 60 years after Hiroshima and 20 years after Chernobyl. JAMA. 2006;295(9):1060–2.PubMedCrossRef Boice JD Jr. Thyroid disease 60 years after Hiroshima and 20 years after Chernobyl. JAMA. 2006;295(9):1060–2.PubMedCrossRef
3.
Zurück zum Zitat Williams D. Twenty years’ experience with post-Chernobyl thyroid cancer. Best Pract Res Clin Endocrinol Metab. 2008;22(6):1061–73.PubMedCrossRef Williams D. Twenty years’ experience with post-Chernobyl thyroid cancer. Best Pract Res Clin Endocrinol Metab. 2008;22(6):1061–73.PubMedCrossRef
4.
Zurück zum Zitat Ron E, Lubin JH, Shore RE, et al. Thyroid cancer after exposure to external radiation: a pooled analysis of seven studies. Radiat Res. 1995;141(3):259–77.PubMedCrossRef Ron E, Lubin JH, Shore RE, et al. Thyroid cancer after exposure to external radiation: a pooled analysis of seven studies. Radiat Res. 1995;141(3):259–77.PubMedCrossRef
5.
Zurück zum Zitat Black P, Straaten A, Gutjahr P. Secondary thyroid carcinoma after treatment for childhood cancer. Med Pediatr Oncol. 1998;31(2):91–5.PubMedCrossRef Black P, Straaten A, Gutjahr P. Secondary thyroid carcinoma after treatment for childhood cancer. Med Pediatr Oncol. 1998;31(2):91–5.PubMedCrossRef
6.
Zurück zum Zitat Garwicz S, Anderson H, Olsen JH, et al. Second malignant neoplasms after cancer in childhood and adolescence: a population-based case–control study in 5 Nordic countries. The Nordic Society for Pediatric Hematology and Oncology. The Association of the Nordic Cancer Registries. Int J Cancer. 2000;88(4):672–8.PubMedCrossRef Garwicz S, Anderson H, Olsen JH, et al. Second malignant neoplasms after cancer in childhood and adolescence: a population-based case–control study in 5 Nordic countries. The Nordic Society for Pediatric Hematology and Oncology. The Association of the Nordic Cancer Registries. Int J Cancer. 2000;88(4):672–8.PubMedCrossRef
7.
Zurück zum Zitat Acharya S, Sarafoglou K, La Quaglia M, et al. Thyroid neoplasms after therapeutic radiation for malignancies during childhood or adolescence. Cancer. 2003;97(10):2397–403.PubMedCrossRef Acharya S, Sarafoglou K, La Quaglia M, et al. Thyroid neoplasms after therapeutic radiation for malignancies during childhood or adolescence. Cancer. 2003;97(10):2397–403.PubMedCrossRef
8.
Zurück zum Zitat Rubino C, Adjadj E, Guérin S, et al. Long-term risk of second malignant neoplasms after neuroblastoma in childhood: role of treatment. Int J Cancer. 2003;107(5):791–6.PubMedCrossRef Rubino C, Adjadj E, Guérin S, et al. Long-term risk of second malignant neoplasms after neuroblastoma in childhood: role of treatment. Int J Cancer. 2003;107(5):791–6.PubMedCrossRef
9.
Zurück zum Zitat Metayer C, Lynch CF, Clarke EA, et al. Second cancers among long-term survivors of Hodgkin’s disease diagnosed in childhood and adolescence. J Clin Oncol. 2000;18(12):2435–43.PubMed Metayer C, Lynch CF, Clarke EA, et al. Second cancers among long-term survivors of Hodgkin’s disease diagnosed in childhood and adolescence. J Clin Oncol. 2000;18(12):2435–43.PubMed
10.
Zurück zum Zitat Neglia JP, Friedman DL, Yasui Y, et al. Second malignant neoplasms in five-year survivors of childhood cancer: childhood Cancer Survivor Study. J Natl Cancer Inst. 2001;93(8):618–29.PubMedCrossRef Neglia JP, Friedman DL, Yasui Y, et al. Second malignant neoplasms in five-year survivors of childhood cancer: childhood Cancer Survivor Study. J Natl Cancer Inst. 2001;93(8):618–29.PubMedCrossRef
11.
Zurück zum Zitat Bhatia S, Yasui Y, Robison LL, et al. High risk of subsequent neoplasms continues with extended follow-up of childhood Hodgkin’s disease: report from the Late Effects Study Group. J Clin Oncol. 2003;21(23):4386–94.PubMedCrossRef Bhatia S, Yasui Y, Robison LL, et al. High risk of subsequent neoplasms continues with extended follow-up of childhood Hodgkin’s disease: report from the Late Effects Study Group. J Clin Oncol. 2003;21(23):4386–94.PubMedCrossRef
12.
Zurück zum Zitat Bhatti P, Veiga LH, Ronckers CM, et al. Risk of second primary thyroid cancer after radiotherapy for a childhood cancer in a large cohort study: an update from the Childhood Cancer Survivor Study. Radiat Res. 2010;174(6):741–52.PubMedCentralPubMedCrossRef Bhatti P, Veiga LH, Ronckers CM, et al. Risk of second primary thyroid cancer after radiotherapy for a childhood cancer in a large cohort study: an update from the Childhood Cancer Survivor Study. Radiat Res. 2010;174(6):741–52.PubMedCentralPubMedCrossRef
13.
Zurück zum Zitat Massimino M, Gandola L, Mattavelli F, et al. Radiation-induced thyroid changes: a retrospective and a prospective view. Eur J Cancer. 2009;45(14):2546–51.PubMedCrossRef Massimino M, Gandola L, Mattavelli F, et al. Radiation-induced thyroid changes: a retrospective and a prospective view. Eur J Cancer. 2009;45(14):2546–51.PubMedCrossRef
14.
Zurück zum Zitat Sobin LH, Wittekind Ch, editors. UICC TNM classification of malignant tumors. 5th ed. New York: Wiley; 1997. Sobin LH, Wittekind Ch, editors. UICC TNM classification of malignant tumors. 5th ed. New York: Wiley; 1997.
15.
Zurück zum Zitat Massimino M, Collini P, Leite SF, et al. Conservative surgical approach for thyroid and lymph node involvement in papillary thyroid carcinoma of childhood and adolescence. Pediatr Blood Cancer. 2006;46(3):307–13.PubMedCrossRef Massimino M, Collini P, Leite SF, et al. Conservative surgical approach for thyroid and lymph node involvement in papillary thyroid carcinoma of childhood and adolescence. Pediatr Blood Cancer. 2006;46(3):307–13.PubMedCrossRef
16.
Zurück zum Zitat Cox R. Regression models and life tables. J R Stat Soc. 1972;34:187–202. Cox R. Regression models and life tables. J R Stat Soc. 1972;34:187–202.
17.
Zurück zum Zitat Kaplan EL, Meier P. Non-parametric estimation from incomplete observation. J Am Stat Assoc. 1958;53:457–81.CrossRef Kaplan EL, Meier P. Non-parametric estimation from incomplete observation. J Am Stat Assoc. 1958;53:457–81.CrossRef
18.
Zurück zum Zitat Veiga LH, Bhatti P, Ronckers CM, et al. Chemotherapy and thyroid cancer risk: a report from the Childhood Cancer Survivor Study. Cancer Epidemiol Biomarkers Prev. 2012;21(1):92–101.PubMedCentralPubMedCrossRef Veiga LH, Bhatti P, Ronckers CM, et al. Chemotherapy and thyroid cancer risk: a report from the Childhood Cancer Survivor Study. Cancer Epidemiol Biomarkers Prev. 2012;21(1):92–101.PubMedCentralPubMedCrossRef
19.
Zurück zum Zitat Tucker MA, Jones PH, Boice JD Jr, et al. Therapeutic radiation at a young age is linked to secondary thyroid cancer. The Late Effects Study Group. Cancer Res. 1991;51(11):2885–8.PubMed Tucker MA, Jones PH, Boice JD Jr, et al. Therapeutic radiation at a young age is linked to secondary thyroid cancer. The Late Effects Study Group. Cancer Res. 1991;51(11):2885–8.PubMed
20.
Zurück zum Zitat Sigurdson AJ, Ronckers CM, Mertens AC, et al. Primary thyroid cancer after a first tumour in childhood (the Childhood Cancer Survivor Study): a nested case–control study. Lancet. 2005;365(9476):2014–23.PubMedCrossRef Sigurdson AJ, Ronckers CM, Mertens AC, et al. Primary thyroid cancer after a first tumour in childhood (the Childhood Cancer Survivor Study): a nested case–control study. Lancet. 2005;365(9476):2014–23.PubMedCrossRef
21.
Zurück zum Zitat Hatipoglu BA, Gierlowski T, Shore-Freedman E, Recant W, Schneider AB. Fine-needle aspiration of thyroid nodules in radiation-exposed patients. Thyroid. 2000;10(1):63–9.PubMedCrossRef Hatipoglu BA, Gierlowski T, Shore-Freedman E, Recant W, Schneider AB. Fine-needle aspiration of thyroid nodules in radiation-exposed patients. Thyroid. 2000;10(1):63–9.PubMedCrossRef
22.
Zurück zum Zitat Sassolas G, Hafdi-Nejjari Z, Casagranda L, et al. Thyroid cancers in children, adolescents, and young adults with and without a history of childhood exposure to therapeutic radiation for other cancers. Thyroid. 2013;23(7):805–10.PubMedCrossRef Sassolas G, Hafdi-Nejjari Z, Casagranda L, et al. Thyroid cancers in children, adolescents, and young adults with and without a history of childhood exposure to therapeutic radiation for other cancers. Thyroid. 2013;23(7):805–10.PubMedCrossRef
23.
Zurück zum Zitat Lee SL. Complications of radioactive iodine treatment of thyroid carcinoma. J Natl Compr Canc Netw. 2010;8(11):1277–86 Review.PubMed Lee SL. Complications of radioactive iodine treatment of thyroid carcinoma. J Natl Compr Canc Netw. 2010;8(11):1277–86 Review.PubMed
24.
Zurück zum Zitat Wada N, Suganuma N, Nakayama H, et al. Microscopic regional lymph node status in papillary thyroid carcinoma with and without lymphadenopathy and its relation to outcomes. Langenbecks Arch Surg. 2007;392(4):417–22.PubMedCrossRef Wada N, Suganuma N, Nakayama H, et al. Microscopic regional lymph node status in papillary thyroid carcinoma with and without lymphadenopathy and its relation to outcomes. Langenbecks Arch Surg. 2007;392(4):417–22.PubMedCrossRef
25.
Zurück zum Zitat Wada N, Sugino K, Mimura T, et al. Treatment strategy of papillary thyroid carcinoma in children and adolescents: clinical significance of the initial nodal manifestation. Ann Surg Oncol. 2009;16(12):3442–9.PubMedCrossRef Wada N, Sugino K, Mimura T, et al. Treatment strategy of papillary thyroid carcinoma in children and adolescents: clinical significance of the initial nodal manifestation. Ann Surg Oncol. 2009;16(12):3442–9.PubMedCrossRef
26.
Zurück zum Zitat Newman KD, Black T, Heller G, et al. Differentiated thyroid cancer: determinants of disease progression in patients <21 years of age at diagnosis: a report from the Surgical Discipline Committee of the Children’s Cancer Group. Ann Surg. 1998;227(4):533–41.PubMedCentralPubMedCrossRef Newman KD, Black T, Heller G, et al. Differentiated thyroid cancer: determinants of disease progression in patients <21 years of age at diagnosis: a report from the Surgical Discipline Committee of the Children’s Cancer Group. Ann Surg. 1998;227(4):533–41.PubMedCentralPubMedCrossRef
27.
Zurück zum Zitat Ji QH, Zhang L, Zhu YX, Huang CP. Long-term impact of initial surgical and medical therapy on young patients with papillary thyroid cancer and bilateral cervical metastases. Chin Med J (Engl). 2008;121(1):63–6. Ji QH, Zhang L, Zhu YX, Huang CP. Long-term impact of initial surgical and medical therapy on young patients with papillary thyroid cancer and bilateral cervical metastases. Chin Med J (Engl). 2008;121(1):63–6.
28.
Zurück zum Zitat Scholz S, Smith JR, Chaignaud B, et al. Thyroid surgery at Children’s Hospital Boston: a 35 year single-institution experience. J Pediatr Surg. 2011;46(3):437–42.PubMedCrossRef Scholz S, Smith JR, Chaignaud B, et al. Thyroid surgery at Children’s Hospital Boston: a 35 year single-institution experience. J Pediatr Surg. 2011;46(3):437–42.PubMedCrossRef
29.
Zurück zum Zitat Armstrong GT, Liu W, Leisenring W, et al. Occurrence of multiple subsequent neoplasms in long-term survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. J Clin Oncol. 2011;29(22):3056–64.PubMedCentralPubMedCrossRef Armstrong GT, Liu W, Leisenring W, et al. Occurrence of multiple subsequent neoplasms in long-term survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. J Clin Oncol. 2011;29(22):3056–64.PubMedCentralPubMedCrossRef
Metadaten
Titel
Thyroid carcinoma after treatment for malignancies in childhood and adolescence: from diagnosis through follow-up
verfasst von
Marta Giorgia Podda
Monica Terenziani
Lorenza Gandola
Paola Collini
Natalia Pizzi
Alfonso Marchianò
Carlo Morosi
Roberto Luksch
Andrea Ferrari
Michela Casanova
Filippo Spreafico
Daniela Polastri
Cristina Meazza
Serena Catania
Elisabetta Schiavello
Veronica Biassoni
Maura Massimino
Publikationsdatum
01.08.2014
Verlag
Springer US
Erschienen in
Medical Oncology / Ausgabe 8/2014
Print ISSN: 1357-0560
Elektronische ISSN: 1559-131X
DOI
https://doi.org/10.1007/s12032-014-0121-6

Weitere Artikel der Ausgabe 8/2014

Medical Oncology 8/2014 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.